GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Praxsyn Corp (GREY:PXYN) » Definitions » Cash Conversion Cycle

Praxsyn (Praxsyn) Cash Conversion Cycle : 18.41 (As of Sep. 2015)


View and export this data going back to 2007. Start your Free Trial

What is Praxsyn Cash Conversion Cycle?

Cash Conversion Cycle is one of several measures of management effectiveness. It equals Days Sales Outstanding + Days Inventory - Days Payable.

Praxsyn's Days Sales Outstanding for the three months ended in Sep. 2015 was 41.32.
Praxsyn's Days Inventory for the three months ended in Sep. 2015 was 19.25.
Praxsyn's Days Payable for the three months ended in Sep. 2015 was 42.16.
Therefore, Praxsyn's Cash Conversion Cycle (CCC) for the three months ended in Sep. 2015 was 18.41.


Praxsyn Cash Conversion Cycle Historical Data

The historical data trend for Praxsyn's Cash Conversion Cycle can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Praxsyn Cash Conversion Cycle Chart

Praxsyn Annual Data
Trend Oct05 Oct06 Oct07 Oct08 Oct09 Dec10 Dec11 Dec12 Dec13 Dec14
Cash Conversion Cycle
Get a 7-Day Free Trial Premium Member Only Premium Member Only -126.42 -110.24 - 92.70 14.18

Praxsyn Quarterly Data
Dec10 Mar11 Jun11 Sep11 Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15
Cash Conversion Cycle Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.31 60.76 43.20 15.92 18.41

Competitive Comparison of Praxsyn's Cash Conversion Cycle

For the Drug Manufacturers - Specialty & Generic subindustry, Praxsyn's Cash Conversion Cycle, along with its competitors' market caps and Cash Conversion Cycle data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Praxsyn's Cash Conversion Cycle Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Praxsyn's Cash Conversion Cycle distribution charts can be found below:

* The bar in red indicates where Praxsyn's Cash Conversion Cycle falls into.



Praxsyn Cash Conversion Cycle Calculation

Cash Conversion Cycle (CCC) measures how fast a company can convert cash on hand into even more cash on hand. This metric looks at the amount of time needed to sell inventory, the amount of time needed to collect receivables and the length of time the company is afforded to pay its bills without incurring penalties.

Cash Conversion Cycle is one of several measures of management effectiveness.

Praxsyn's Cash Conversion Cycle for the fiscal year that ended in Dec. 2014 is calculated as

Cash Conversion Cycle=Days Sales Outstanding +Days Inventory-Days Payable
=37.54+10.94-34.3
=14.18

Praxsyn's Cash Conversion Cycle for the quarter that ended in Sep. 2015 is calculated as:

Cash Conversion Cycle=Days Sales Outstanding+Days Inventory-Days Payable
=41.32+19.25-42.16
=18.41

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Praxsyn  (GREY:PXYN) Cash Conversion Cycle Explanation

Generally, the lower this number is, the better for the company. Although it should be combined with other metrics (such as ROE % and ROA %), it can be especially useful for comparing close competitors, because the company with the lowest CCC is often the one with better management.


Be Aware

CCC is most effective with retail-type companies, which have inventories that are sold to customers. Consulting businesses, software companies and insurance companies are all examples of companies for whom this metric is meaningless.

The CCC is one of several tools that can help you evaluate management, especially if it is calculated for several consecutive time periods and for several competitors. Decreasing or steady CCCs are good, while rising ones should motivate you to dig a bit deeper.


Praxsyn Cash Conversion Cycle Related Terms

Thank you for viewing the detailed overview of Praxsyn's Cash Conversion Cycle provided by GuruFocus.com. Please click on the following links to see related term pages.


Praxsyn (Praxsyn) Business Description

Traded in Other Exchanges
N/A
Address
61 Spectrum Boulevard, Suite A, Las Vegas, NV, USA, 89101
Praxsyn Corp is a healthcare company, dedicated to providing medical practitioners with medications and services for their patients. Through its retail pharmacy facility, it formulates healthcare practitioner-prescribed medications to serve patients who experience chronic pain. It primarily focuses on non-narcotic and non-habit forming medications using therapeutic and preventative agents for pain management. In addition, the group prepares innovative products that address erectile dysfunction and metabolic issues and other ancillary products. The products of the firm are either picked up directly from pharmacy facility or shipped directly to patients. The business activities are functioned through the regions of United States.